Cefaclor capsules |
Ceclor |
Article: Cefaclor
![]() | |
| Cefaclor | |
| Systematic (IUPAC) name | |
| 7-[(2-amino-2-phenyl-acetyl)amino]- 3-chloro-8-oxo-5-thia-1-azabicyclo [4.2.0] oct-2- ene-2- carboxylic acid | |
| Identifiers | |
| CAS number | 53994-73-3 |
| ATC code | J01DC04 |
| PubChem | 2609 |
| DrugBank | APRD00243 |
| Chemical data | |
| Formula | C15H14ClN3O4S |
| Mol. weight | 367.808 |
| Pharmacokinetic data | |
| Bioavailability | Well absorbed, independent of food intake |
| Metabolism | 15% to 40% |
| Half life | 0.6 - 0.9 hours |
| Excretion | renal |
| Therapeutic considerations | |
| Pregnancy cat. | ? |
| Legal status | ℞ Prescription only |
| Routes | Oral |
Cefaclor, also known as cefachlor, (brand names Ceclor®, Distaclor®, Keflor®, Raniclor®) is a 2nd-generation cephalosporin antibiotic used to treat certain infections caused by bacteria such as pneumonia and ear, lung, skin, throat, and urinary tract infections.

Not Signed In - 

